Santa Sp. z o.o. sp. K.Polimedica PTG Kielce
- Address
- lock Available on a paid plan
Santa Sp. z o.o. sp. K.Polimedica PTG Kielce - Dermatology and Immunology Research
Santa Sp. z o.o. sp. K.Polimedica PTG Kielce is a specialized clinical research center in Poland dedicated to advancing dermatological and immunological treatments. The facility focuses on investigating innovative therapies for chronic skin conditions, with particular expertise in allergic and immune-mediated disorders affecting quality of life.
- Chronic Spontaneous Urticaria clinical trials
- Phase 3 therapeutic interventions for dermatologic conditions
- Novel biologic therapies and immunomodulatory treatments
The center's research portfolio includes cutting-edge studies evaluating barzolvolimab and other advanced biologics for managing chronic spontaneous urticaria, utilizing validated outcome measures such as the weekly urticaria activity score (UAS7). Through participation in multinational clinical trials, the facility contributes to the development of breakthrough treatments that address unmet medical needs in dermatology and immunology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Santa Sp. z o.o. sp. K.Polimedica PTG Kielce
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis | Abivax | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Obefazimod | 4 | Unknown | 2023-06-08 | 2025-01-27 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.